Charcot-Marie-Tooth type 1A disease caused by a novel Ser112Arg mutation in thePMP22 gene, coexisting with a slowly progressive hearing impairment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aarskog NK, Vedeler C, 2000. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 107: 494–498.
Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K, et al. 2002. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 51: 190–201.
Cowchock FS, Duckett SW, Streletz LJ, Graziani LJ, Jackson LG, 1985. X-linked motor sensory neuropathy type-II with deafness and mental retardation: a new disorder. Am J Med Genet 20: 307–315.
De Weerdt CJ, Heerspink W, 1974. Family with Charcot-Marie-Tooth disease showing unusual biochemical-clinical and genetic features. Eur Neurol 12: 253–260.
Huehne K, Benes V, Thiel C, Kraus C, Kress W, Hoeltzenbein M, et al. 2003. Novel mutations in the Charcot-Marie-Tooth disease genesPMP22, MPZ, andGJB1. Hum Mut Mut 21: 100.
Ionasescu VV, Searby C, Greenberg SA, 1996. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of thePMP22 gene. J Med Genet 30: 1048–1049.
Jen J, Baloh RH, Ishiyama A, Baloh RW, 2005. Dejerine-Sottas syndrome and vestibular loss due to a point mutation in thePMP22 gene. Journal of the Neurological Sciences 237: 21–24.
Joo IS, Ki CS, Joo SY, Huh K, Kim JW, 2004. A novel point mutation inPMP22 gene associated with a familial case of Charcot-Marie-Tooth disease type 1A with sensorineural deafness. Neuromuscular Disorders 14: 325–328.
Kabzińska D, Korwin-Piotrowska T, Drechsler H, Drac H, Hausmanowa-Petrusewicz I, Kochański A, 2007. Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro 105 Thr mutation in theMPZ gene. Am J Med Genet 143A: 2196–2199.
Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, et al. 1996. Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet 14: 214–217.
Kovach MJ, Lin JP, Boyadjiev S, Campbell K, Mazzeo L, Herman K, et al. 1999. A unique point mutation in thePMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. Am J Hum Genet 64: 1580–1593.
Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. 1991. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219–232.
Naef R, Suter U, 1999. Impaired intracellular trafficking is a common disease mechanism ofPMP22 point mutations in peripheral neuropathies. Neurobiology of disease 6: 1–14.
Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. 1991. Duplication in chromosome 17p1 1.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromusc. Disord. 1: 93–101.
Sambuughin N, de Bantel A, McWilliams S, Sivakumar K, 2003. Deafness and CMT disease associated with a novel four amino acid deletion in thePMP22 gene. Neurology 60: 506–508.
Seeman P, Mazanec R, Huehne K, Suslíková P, Keller O, Rautenstrauss B, 2004. Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology 63: 733–735.
Suter U, Snipes GJ, 1995. Peripheral myelin protein 22: facts and hypotheses. Journal of Neuroscience Research 40: 145–151.